Stay updated on BCMA CAR T Cells in Myeloma Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR T Cells in Myeloma Clinical Trial page.

Latest updates to the BCMA CAR T Cells in Myeloma Clinical Trial page
- Check2 days agoChange DetectedRecord History now includes a new revision entry (v3.3.4) and a removed entry (v3.3.3). This reflects an update to the study's revision history metadata and does not alter the study content or results.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new Revision: v3.3.3 was added to the record history, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the page footer and history.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study record versions show a new revision entry v3.3.2 added and old revision v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe government funding and operating status notice on the ClinicalTrials.gov record page for NCT03093168 was removed.SummaryDifference0.8%

- Check73 days agoChange DetectedVersion history shows updates to Study Status, Recruitment Status, and Eligibility criteria for the trial.SummaryDifference0.1%

- Check102 days agoChange DetectedThe page now includes a government-operating-status notice and announces version v3.2.0, replacing the previous v3.1.0.SummaryDifference13%

Stay in the know with updates to BCMA CAR T Cells in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR T Cells in Myeloma Clinical Trial page.